Status:
UNKNOWN
Obstructive Sleep Apnea, CPAP Treatment & Cognitive Ability in HIV
Lead Sponsor:
McGill University
Collaborating Sponsors:
VitalAire
ResMed
Conditions:
Hiv
Obstructive Sleep Apnea
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) is a breathing disorder that is characterized by episodes of complete or partial cessation of respiration during sleep, associated with upper airway collapse, oxygen desa...
Detailed Description
Definition of obstructive sleep apnea: Obstructive sleep apnea (OSA) is a breathing disorder that is characterized by episodes of complete or partial cessation of respiration during sleep, associated...
Eligibility Criteria
Inclusion
- Participants in the cohort study "Understanding and Optimizing Brain Health in HIV Now"
- Screened positive for OSA using the Berlin or the STOP-BANG (completed as part of the main study visits)
- Have been on a stable HAART regimen for \> 6 months
- B-CAM ≤ 29
- Have not had a change in medications that could potentially interfere with sleep or cognition in the past 4 months.
- Willing to use CPAP as per instructions
- Able to comply with follow-up visit assessments
- Able to communicate in English or French
- Have at least one remaining visit in the main cohort study
Exclusion
- Already treated for OSA
- Ongoing involvement in night shift work
- Presence of restless legs syndrome requiring immediate specific treatment
Key Trial Info
Start Date :
June 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 13 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03478137
Start Date
June 5 2017
End Date
September 13 2021
Last Update
September 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Center
Montreal, Quebec, Canada, H4A 3J1